Accueil
MA

Mo Alavijeh

211
9
5

À Propos du Membre

Biographie

Mo is a science entrepreneur with over 30 years’ experience in the pharmaceutical industry, having responsibilities as wide-ranging as R&D and innovation, business development and strategic alliances at Pharmidex. He was previously head of drug metabolism, DMPK/PD at Vernalis Research, before which he was DMPK team leader at Aventis Pharma (Sanofi). Mo is visiting Professor at University of Hertfordshire and a fellow of the Royal Society of Chemistry (FRSC) and the Royal Society for Medicine (FRSM).

Expérience

EF

MANAGEMENT TRAINING

EFMC

01/201701/2017

Financial Management of European Commission Projects,

UO

Executive Education

University of Cambridge

01/201401/2014

International Business Growth

HB

Strategic Financial Analysis for Business Evaluation

Harvard Business School

01/201201/2012

Executive Education

UC

MBI Modules

University College, London

01/201001/2010

Bioprocess Design & Economic Evaluation

II

Marketing Strategy

Indian Institute of Management Ahmedabad

01/200901/2009

Executive Education

P(

Chief Operation Officer

Pharmidex (United Kingdom)

01/200601/2008

R&D

P(

CHIEF SCIENTIFIC OFFICER

Pharmidex (United Kingdom)

01/200201/2006

R&D

VL

Department Head

Vernalis Ltd

01/200001/2002

DMPK

SU

Team Leader

Sanofi-Aventis US LLC

01/199201/2000

DMPK

UC

Research Scientist

University College London Institute of Neurology

01/199001/1992

Clinical Neurology - TDM

UI

Institute of neurology, Studied for PhD

UCL Institute of Neurology, University College London

01/198701/1990

Clinical Neurology - TDM

KC

Institue of Psychiatry, MSc

King's College School

01/198601/1987

Neurochemistry